Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Solubility properties of chlorhexidine salts.

Zeng P, Rao A, Wiedmann TS, Bowles W.

Drug Dev Ind Pharm. 2009 Feb;35(2):172-6. doi: 10.1080/03639040802220318 .

PMID:
18785046
2.

Concentration dependent aggregation properties of chlorhexidine salts.

Zeng P, Zhang G, Rao A, Bowles W, Wiedmann TS.

Int J Pharm. 2009 Feb 9;367(1-2):73-8. doi: 10.1016/j.ijpharm.2008.09.031. Epub 2008 Sep 25.

PMID:
18926892
3.

Adsorption of chlorhexidine on synthetic hydroxyapatite and in vitro biological activity.

de Souza CA, Colombo AP, Souto RM, Silva-Boghossian CM, Granjeiro JM, Alves GG, Rossi AM, Rocha-Leão MH.

Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):310-8. doi: 10.1016/j.colsurfb.2011.05.035. Epub 2011 May 27.

PMID:
21676601
4.
5.

Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery.

Senel S, Ikinci G, Kaş S, Yousefi-Rad A, Sargon MF, Hincal AA.

Int J Pharm. 2000 Jan 5;193(2):197-203.

PMID:
10606782
6.

Interaction of chlorhexidine with smooth and rough types of titanium surfaces.

Kozlovsky A, Artzi Z, Moses O, Kamin-Belsky N, Greenstein RB.

J Periodontol. 2006 Jul;77(7):1194-200.

PMID:
16805682
7.

Detection of para-chloroaniline, reactive oxygen species, and 1-chloro-4-nitrobenzene in high concentrations of chlorhexidine and in a mixture of chlorhexidine and calcium hydroxide.

Barbin LE, Estrela C, Guedes DF, Spanó JC, Sousa-Neto MD, Pécora JD.

J Endod. 2013 May;39(5):664-8. doi: 10.1016/j.joen.2012.10.018. Epub 2012 Nov 28.

PMID:
23611387
8.

Combining in the melt physical and biological properties of poly(caprolactone) and chlorhexidine to obtain antimicrobial surgical monofilaments.

Scaffaro R, Botta L, Sanfilippo M, Gallo G, Palazzolo G, Puglia AM.

Appl Microbiol Biotechnol. 2013 Jan;97(1):99-109. doi: 10.1007/s00253-012-4283-x. Epub 2012 Jul 21.

PMID:
22821439
9.

Effects of single intratracheal exposure to chlorhexidine gluconate on the rat lung.

Orito K, Hashida M, Hirata K, Kurokawa A, Shirai M, Akahori F.

Drug Chem Toxicol. 2006 Jan;29(1):1-9.

PMID:
16455586
10.

[Influence of quaternary ammonium salt on liberation of drug with antiseptic effect].

Vitková Z, Herdová P, Oremusová J, Cižmárik J, Tóthová K.

Ceska Slov Farm. 2013 Dec;62(6):255-8. Czech.

PMID:
24393113
11.

Chlorhexidine release from room temperature polymerising methacrylate systems.

Riggs PD, Braden M, Patel M.

Biomaterials. 2000 Feb;21(4):345-51.

PMID:
10656315
12.

Nanoparticles for controlled delivery and sustained release of chlorhexidine in the oral environment.

Garner S, Barbour ME.

Oral Dis. 2015 Jul;21(5):641-4. doi: 10.1111/odi.12328. Epub 2015 Apr 6.

PMID:
25703954
13.

Systemic toxicity following ingestion of the chlorhexidine gluconate solution: a case report.

Kolahi J, Ghalayani P, Varshosaz J.

J Int Acad Periodontol. 2006 Apr;8(2):45-6.

PMID:
16623178
14.

Examination of the physical state of chlorhexidine within viscoelastic, bioadhesive semisolids using raman spectroscopy.

Jones DS, Brown AF, Woolfson AD, Dennis AC, Matchett LJ, Bell SE.

J Pharm Sci. 2000 May;89(5):563-71.

PMID:
10756321
15.

Chlorhexidine: expanding the armamentarium for infection control and prevention.

Milstone AM, Passaretti CL, Perl TM.

Clin Infect Dis. 2008 Jan 15;46(2):274-81. doi: 10.1086/524736. Review.

PMID:
18171263
16.

Formation of salts.

Gaibi M.

Br Dent J. 2006 Jan 28;200(2):64-5; author reply 65. No abstract available.

PMID:
16444202
17.

Antibacterial polyurethane nanocomposites using chlorhexidine diacetate as an organic modifier.

Fong N, Simmons A, Poole-Warren LA.

Acta Biomater. 2010 Jul;6(7):2554-61. doi: 10.1016/j.actbio.2010.01.005. Epub 2010 Jan 13.

PMID:
20074676
18.

Chlorhexidine gluconate: an ideal scolicidal agent in the treatment of intraperitoneal hydatidosis?

Puryan K, Karadayi K, Topcu O, Canbay E, Sumer Z, Turan M, Karayalcin K, Sen M.

World J Surg. 2005 Feb;29(2):227-30.

PMID:
15650798
19.

Study on the release of chlorhexidine base and salts from different liquid crystalline structures.

Farkas E, Kiss D, Zelkó R.

Int J Pharm. 2007 Aug 1;340(1-2):71-5. Epub 2007 Mar 30.

PMID:
17467206
20.

Dilute solution properties of clindamycin 2-palmitate hydrochloride.

Abbott TI, Benton DP, Hampson CA.

J Pharm Pharmacol. 1977 Sep;29(9):529-32.

PMID:
21255

Supplemental Content

Support Center